
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **CRISP3**: Known to be involved in immune response and is often associated with prostate and breast cancer.<br>- **CXCL13**: A chemokine involved in B-cell chemotaxis and is often associated with lymphoid tissues.<br>- **EEF1A2**: A translation elongation factor, often overexpressed in various cancers.<br>- **S100P**: A member of the S100 family of proteins, often associated with cancer progression and metastasis.<br>- **FASN**: Fatty acid synthase, involved in lipid biosynthesis, often upregulated in cancer cells.<br>- **NQO1**: An enzyme involved in detoxification processes, often upregulated in cancer cells.<br>- **TRPS1**: A transcription factor involved in the regulation of cell growth and differentiation, often associated with breast cancer.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT19**: A keratin protein, often used as a marker for epithelial cells, particularly in breast cancer.<br>- **GJA1**: Also known as Connexin 43, involved in cell communication, often found in epithelial cells.<br>- **S100A14**: Part of the S100 protein family, associated with epithelial cells and cancer.<br>- **STARD10**: Involved in lipid transport, often associated with breast cancer epithelial cells.<br>- **ADIRF**: Adipogenesis regulatory factor, associated with adipocytes but also expressed in some cancer cells.<br>- **CRIP1**: Cysteine-rich protein, often associated with epithelial cells and cancer.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **KRT19** and **S100P** are strongly associated with epithelial cells, particularly in breast tissue.<br>- **CXCL13** is more commonly associated with immune cells, particularly B-cells, but its presence in this context may indicate a tumor microenvironment interaction.<br>- **FASN** and **NQO1** are markers often upregulated in cancerous epithelial cells.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **epithelial cells**, specifically those associated with breast tissue. The presence of markers like KRT19, S100P, and STARD10 strongly supports this classification.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Breast Cancer Epithelial Cells**: Given the presence of KRT19, S100P, and other cancer-associated markers like FASN and NQO1, this is the most likely subtype.<br>2. **Luminal Epithelial Cells**: These cells are characterized by the expression of KRT19 and other markers associated with luminal differentiation.<br>3. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers, the presence of general epithelial markers could suggest this subtype.<br><br>The most likely subtype, based on the markers, is **Breast Cancer Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically breast cancer epithelial cells. This conclusion is supported by the presence of key epithelial markers such as KRT19 and S100P, along with cancer-associated markers like FASN and NQO1. The expression profile aligns with known characteristics of breast cancer epithelial cells, making this the most probable cell type.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    To validate the annotation result, let's follow the outlined steps:<br><br>### Step 1: Marker Consistency<br>- **Markers in the Provided List**: The markers used in the annotation (CRISP3, CXCL13, EEF1A2, S100P, FASN, NQO1, TRPS1, KRT19, GJA1, S100A14, STARD10, ADIRF, CRIP1) are all present in the provided marker list.<br>- **Consistency with Identified Cell Type**: The markers KRT19, S100P, and STARD10 are strongly associated with epithelial cells, particularly in breast tissue, which supports the annotation of breast cancer epithelial cells. FASN and NQO1 are also consistent with cancerous epithelial cells.<br><br>### Step 2: Mixed Cell Type Consideration<br>- **Potential Mixed Cell Types**: The presence of CXCL13, which is more commonly associated with immune cells, particularly B-cells, suggests a potential interaction with the tumor microenvironment. However, the majority of high-ranking markers support the epithelial cell type, specifically breast cancer epithelial cells. There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided.<br><br>### Conclusion<br>The annotation of the cell cluster as breast cancer epithelial cells is consistent with the provided marker list and the known associations of these markers. The presence of CXCL13 does not strongly suggest a mixed cell type population in this context, but it may indicate some level of interaction with the immune environment, which is common in cancer tissues.<br><br>Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Breast Cancer Epithelial Cells</li><li>Luminal Epithelial Cells</li><li>Basal Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from human breast cancer tissue. The analysis is well-structured, following a logical sequence of steps that include listing key functional and cell type markers, cross-referencing with known databases, and determining the most probable general and sub-cell types.<br><br>1. **Correctness of the Annotations**: The final annotation identifies the main cell type as epithelial cells, specifically breast cancer epithelial cells, which is consistent with the presence of markers such as KRT19, S100P, and STARD10. These markers are well-documented in the literature as being associated with epithelial cells in breast tissue, particularly in the context of cancer. The inclusion of cancer-associated markers like FASN and NQO1 further supports this classification.<br><br>2. **Balanced Consideration of Multiple Markers**: The annotation process considers a wide range of markers, including those associated with cancer progression (e.g., S100P, FASN) and those specific to epithelial cells (e.g., KRT19, GJA1). The analysis does not overly focus on a single marker but instead integrates information from multiple sources to arrive at a comprehensive conclusion.<br><br>3. **Ability to Capture the General Picture**: The annotation captures the general picture of the cell populations present, identifying the primary cell type and potential subtypes. The consideration of CXCL13, a marker associated with immune cells, indicates an awareness of the tumor microenvironment, although it is not deemed significant enough to suggest a mixed cell type population.<br><br>4. **Consideration of Marker Rank**: The analysis does not explicitly discuss the rank of the markers, which could be an area for improvement. While the presence of high-ranking markers like CRISP3 and CXCL13 is noted, their specific importance relative to other markers is not fully explored.<br><br>5. **Potential Oversights**: While the annotation is generally accurate, the presence of CXCL13 could suggest a more significant role of immune cells in the dataset than acknowledged. This could be an area for further exploration, especially given the importance of the tumor microenvironment in cancer biology.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present. The analysis could be enhanced by a more explicit consideration of marker rank and a deeper exploration of potential mixed cell types.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    